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Abstract:                                                                                                                                    
With various antibiotics becoming illegitimate due to bacteria building up resistance to them, it 
becomes imperative to find new antibiotics to replace the ones that no longer work. In theory, 
this can be accomplished by inhibiting the IspF enzyme which can be found within the 
Methylerythritol phosphate (MEP) pathway. Four different cell cultures, one treated and 
containing no IPTG, one treated and containing IPTG, a control with IPTG, and a control lacking 
IPTG were found to have grown successfully at a steady pace over a period of 5 hours. This 
means that the overexpression of IspF within the cell cultures does not affect their ability to grow 
at a steady rate. An overexpression of IspF resulted in a large peak pertaining to CMP, whereas 
an unaltered sample lacked a defined peak. This should be useful in future work because it will 
be easier to see if potential inhibitors are successful. 
Introduction: 
Medicine changed forever in 1928 with the realization that Penicillin notatum could stop bacteria 
from growing. In the early 1940s, patients suffering from life-threatening bacterial infections 
started to receive penicillin as treatment and as a result usually made a speedy recovery.1 
However, bacteria have the capability to quickly become 
resistant to antibiotics and this has caused some to die from 
infections once again. Since bacteria reproduce so rapidly, 
scientists must create and test new antibiotics to replace the ones 
that are in use now. The Methylerythritol Phosphate (MEP) pathway has recently taken center 
stage in the production of new antibiotics.  




By utilizing a two-step method involving screening and time-based studies, an in-vivo cell 
growth and cell lysis method compatible with High Performance Liquid Chromatography 
(HPLC) is capable of being developed. This methodology is used to test potential inhibitors of 
the MEP pathway. Use of the MEP pathway in drug development is beneficial because this 
pathway is 
exclusive to 
bacteria. Since the 
MEP pathway is 
absent in humans, 
plants, and 
animals, they must rely more heavily on the mevalonate (MVA) pathway.4 The MEP pathway, as 
seen in Figure 2, is made up of seven different enzymes that a potential antibiotic can be 
designed to target particularly.5 The enzyme this experiment will focus specifically on is IspF. 
IspF is necessary for the transformation of CDPME2P into MEcDP to occur. When this 
transition takes place, the compound CMP is given off as a by-product of the reaction. This 
becomes advantageous when one realizes that potential inhibitors should block this compound 
from forming. By implementing LC/MS, cells containing potential drugs can be screened to see 
whether they contain CMP or not. If the data lacks a peak for CMP, then the antibiotic works.  
Experimental Procedure: 
By following the protocol for cell lysis, E. coli cells containing IspF from the pathogen 
Burkholderia pseudomallei that were held in a frozen cell pellet were allowed to dissolve in 30 
mL of 100 mM Tris lysis buffer with a pH of 8.0. A digital sonicator was utilized to break open 
the cells. These cells were then placed into a centrifuge at 15,000 x g for 20 minutes at 4ºC. 




Afterwards, organic solvent was added and the resulting mixture was placed into the centrifuge 
once again.  Then the cell supernatant was collected for future LC/MS analysis of the cells. In a 
separate experiment, the optical density was recorded for four different cell cultures including a 
control containing no IPTG, a control with IPTG, one treated culture containing IPTG, and one 
treated culture containing no IPTG after 0 hours, 1 hour, 3 hours, and 5 hours. The resulting data 
was studied to determine how similar or dissimilar the cell growth was for each of the cell 
cultures. 
Results and Discussion: 
The four different cell cultures were graphed together so that a clear picture for the cell growth 
over time could be ascertained. The following depiction illustrates that the overexpression of 
IspF within cell cultures does not have any negating effects on cell growth rate. 
 






Figure 4 was created to show what spectra could be expected to look like if BpIspF in the XL-1 
Blue cells was not overexpressed and no inhibitor was present. 
 
 
Figure 4: E. Coli Lysate 
Figure 5 was generated to show what the spectra would look like once the overexpression of IspF 
in the sample had occurred. A larger peak for CMP in the spectra was found to occur after the 
overexpression of IspF. This was considered to be logical since CMP is a product of IspF. 
Thereby, more IspF would make the signal for CMP larger and clearer. This will be useful in 
later experiments because it will make it easier to tell whether the potential IspF inhibitors work 





Figure 5: E. Coli Lysate with IspF overexpressed 
 
Conclusion: 
The cells were found to have grown steadily and successfully over the span of 5 hours. A large 
peak pertaining to CMP from the overexpression of IspF in E. Coli was also observed. This 
meant that if the inhibitor had success targeting the IspF enzyme within the MEP pathway, there 
would be a marked difference between its spectra and that of an inhibitor that did not work. In 
other words, if the inhibitor was found to be effective, then no CMP peak would be seen in the 
resulting spectra. Future work should encompass varying the conditions of the E. coli cell 
cultures containing Burkholderia pseudomallei IspF. These constraints could include whether the 
cell cultures contain an inhibitor or not, the concentration, and the type of inhibitor utilized.   
Acknowledgments: 
I would like to thank Dr. Ryzhov, Allison Fabino-Carr, and the rest of the Ryzhov group for their 






1Discovery and Development of Penicillin. 
https://www.acs.org/content/acs/en/education/whatischemistry/landmarks/flemingpenicill
in.html (accessed April 5, 2017). 
2Worthington, R. J.; Melander, C. J. Org. Chem. 2013, 78, 4207-4213. 
3Narayanasamy, P.; Eoh, H.; Brennan, P. J.; Crick, D. C. Chem. Biol. 2010, 17, 117-122. 
4Frank, A.; Groll, M. Chem Rev. 2016, A-AC. 
5Bitok, J. K.; Meyers, C. F. ACS Chem. Biol. 2012, 7, 1702-1710. 
 
 
 
 
 
